Published in Infect Immun on August 13, 2007
Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine (2010) 1.18
Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One (2008) 1.14
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One (2009) 0.90
Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci (2010) 0.89
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol (2009) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerg Infect Dis (2012) 0.88
T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One (2010) 0.87
The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun (2009) 0.87
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol (2009) 0.84
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect Immun (2014) 0.82
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infect Immun (2012) 0.79
Contribution of pertussis toxin to the pathogenesis of pertussis disease. Pathog Dis (2015) 0.78
Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes. Infect Immun (2014) 0.77
Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis. J Vet Med Sci (2016) 0.75
Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms. PLoS One (2017) 0.75
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet (2003) 9.13
Ecological and immunological determinants of influenza evolution. Nature (2003) 7.60
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
The maintenance of strain structure in populations of recombining infectious agents. Nat Med (1996) 4.31
Opposite patterns of synchrony in sympatric disease metapopulations. Science (1999) 3.38
Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J (2005) 3.14
Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J Bacteriol (1991) 3.12
Pertussis of adults and infants. Lancet Infect Dis (2002) 2.95
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog (2005) 2.71
Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis (1999) 2.55
The changing age and seasonal profile of pertussis in Canada. J Infect Dis (2002) 2.53
Pertussis. Medicine (Baltimore) (1975) 2.41
Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29
Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23
Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol (1997) 2.14
How best to estimate the global burden of pertussis? Lancet Infect Dis (2003) 2.08
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J (1994) 1.90
Ecological interference between fatal diseases. Nature (2003) 1.87
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine (1998) 1.86
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 1.84
Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83
Host adaptation and the emergence of infectious disease: the Salmonella paradigm. Mol Microbiol (2000) 1.81
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun (2000) 1.77
Exploring the evolution of diversity in pathogen populations. Trends Microbiol (2001) 1.72
Role of antibodies in immunity to Bordetella infections. Infect Immun (2003) 1.71
Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun (2007) 1.64
Epidemics of parapertussis. 20 years' observations in Denmark. Lancet (1971) 1.63
O-antigenic chains of lipopolysaccharide prevent binding of antibody molecules to an outer membrane pore protein in Enterobacteriaceae. Microb Pathog (1986) 1.61
Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol (1998) 1.61
Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide. J Bacteriol (1986) 1.61
Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun (1999) 1.59
Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med (2000) 1.55
Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin Infect Dis (1992) 1.53
Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia. Infect Immun (1986) 1.37
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther (2004) 1.27
Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog (2006) 1.26
Evolution and emergence of Bordetella in humans. Trends Microbiol (2005) 1.25
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect Immun (2004) 1.09
Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun (2001) 1.03
Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine (2004) 1.02
Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child (2003) 1.01
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun (2005) 1.00
Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis. Immunol Lett (1999) 0.99
An O antigen can interfere with the function of the Yersinia pseudotuberculosis invasin protein. Mol Microbiol (1991) 0.99
Evolutionary pressures in the spread and persistence of infectious agents in vertebrate populations. Parasitology (1995) 0.98
Lipopolysaccharide O antigen chains mask IcsA (VirG) in Shigella flexneri. FEMS Microbiol Lett (2003) 0.96
Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc Biol Sci (2006) 0.95
Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis (1999) 0.95
From the Centers for Disease Control and Prevention. Pertussis--United States, 1997-2000. JAMA (2002) 0.89
PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population. J Med Microbiol (2003) 0.85
The 2001 serological survey in the Czech Republic--parapertussis. Cent Eur J Public Health (2003) 0.82
A causal relationship between Bordetella pertussis and Bordetella parapertussis infections. Scand J Infect Dis (1996) 0.80
Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland. Eur J Clin Microbiol Infect Dis (2004) 0.79
The 2001 serological survey in the Czech Republic--pertussis. Cent Eur J Public Health (2003) 0.78
Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol (2008) 1.78
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Role of antibodies in immunity to Bordetella infections. Infect Immun (2003) 1.71
Molecular signature of hypersaline adaptation: insights from genome and proteome composition of halophilic prokaryotes. Genome Biol (2008) 1.64
A framework for the study of zoonotic disease emergence and its drivers: spillover of bat pathogens as a case study. Philos Trans R Soc Lond B Biol Sci (2012) 1.61
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Rural-urban gradient in seasonal forcing of measles transmission in Niger. Proc Biol Sci (2010) 1.45
A dynamic view of the spread and intracellular distribution of Salmonella enterica. Nat Rev Microbiol (2009) 1.38
Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes. J Bacteriol (2004) 1.36
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun (2006) 1.31
Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics (2012) 1.30
Evidence-based control of canine rabies: a critical review of population density reduction. J Anim Ecol (2012) 1.26
Evolution and emergence of Bordetella in humans. Trends Microbiol (2005) 1.25
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun (2005) 1.23
MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun (2005) 1.22
Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine (2010) 1.18
Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis (2004) 1.14
Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun (2004) 1.13
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol (2005) 1.13
Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol (2004) 1.10
The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol (2005) 1.08
Demography of straw-colored fruit bats in Ghana. J Mammal (2012) 1.07
pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun (2004) 1.06
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One (2009) 1.01
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun (2005) 1.00
Evolution of acute infections and the invasion-persistence trade-off. Am Nat (2009) 0.98
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Dynamics of Salmonella infection of macrophages at the single cell level. J R Soc Interface (2012) 0.95
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect (2007) 0.91
Seasonality, cohort-dependence and the development of immunity in a natural host-nematode system. Proc Biol Sci (2008) 0.91
Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun (2010) 0.91
Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. J Infect Dis (2007) 0.91
Measles on the edge: coastal heterogeneities and infection dynamics. PLoS One (2008) 0.90
Characteristics and Risk Perceptions of Ghanaians Potentially Exposed to Bat-Borne Zoonoses through Bushmeat. Ecohealth (2014) 0.90
Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun (2007) 0.90
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One (2009) 0.90
Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci (2010) 0.89
Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells. Immunology (2011) 0.89
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol (2009) 0.89
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun (2013) 0.89
Constraint-based network model of pathogen-immune system interactions. J R Soc Interface (2008) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerg Infect Dis (2012) 0.88
Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun (2004) 0.87
The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun (2009) 0.87
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection. Cell Microbiol (2006) 0.85
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun (2009) 0.83
Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun (2003) 0.82
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res (2007) 0.81
Exposure to Bat-Associated Bartonella spp. among Humans and Other Animals, Ghana. Emerg Infect Dis (2016) 0.80
Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol (2012) 0.80
sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice. BMC Microbiol (2012) 0.79
Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infect Immun (2012) 0.79
Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. PLoS Pathog (2010) 0.79
Resident microbiota affect Bordetella pertussis infectious dose and host specificity. J Infect Dis (2013) 0.78
Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. BMC Evol Biol (2013) 0.77
Identification of a CO2 responsive regulon in Bordetella. PLoS One (2012) 0.77
Life in cells, hosts, and vectors: parasite evolution across scales. Infect Genet Evol (2012) 0.77
Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. J Biol Chem (2010) 0.76
Modelling the dynamics of an experimental host-pathogen microcosm within a hierarchical Bayesian framework. PLoS One (2013) 0.75
Teaching ethical aptitude to graduate student researchers. Account Res (2013) 0.75
Correction to 'Single passage in mouse organs enhances the survival and spread of Salmonella enterica'. J R Soc Interface (2016) 0.75